Pregled bibliografske jedinice broj: 517455
HFE MUTACIJE I C1/C2 POLIMORFIZAM GENA ZA TRANSFERIN U HRVATSKIH BOLESNIKA SA SHIZOFRENIJOM I SHIZOAFEKTIVNIM POREMEĆAJEM
HFE MUTACIJE I C1/C2 POLIMORFIZAM GENA ZA TRANSFERIN U HRVATSKIH BOLESNIKA SA SHIZOFRENIJOM I SHIZOAFEKTIVNIM POREMEĆAJEM // The Seventh ISABS Conference in Forensic, Anthropologic and Medical Genetics and Mayo Clinic Lectures in Translational Medicine ; Final Program and Abstracts / Schanfield, Moses ; Primorac, Dragan ; Vuk-Pavlović, Stanimir (ur.).
Bol, Hrvatska, 2011. str. 246-246 (predavanje, međunarodna recenzija, sažetak, znanstveni)
CROSBI ID: 517455 Za ispravke kontaktirajte CROSBI podršku putem web obrasca
Naslov
HFE MUTACIJE I C1/C2 POLIMORFIZAM GENA ZA TRANSFERIN U HRVATSKIH BOLESNIKA SA SHIZOFRENIJOM I SHIZOAFEKTIVNIM POREMEĆAJEM
(HFE MUTATIONS AND TRANSFERRIN C1/C2 POLYMORPHISM AMONG CROATIAN PATIENTS WITH SCHIZOPHRENIA AND SCHIZOAFFECTIVE DISORDER)
Autori
Buretić-Tomljanović, Alena ; Vraneković, Jadranka ; Rubeša, Gordana ; Jonovska, Suzana ; Tomljanović, Draško ; Šendula-Jengić, Vesna ; Kapović, Miljenko ; Ristić, Smiljana
Vrsta, podvrsta i kategorija rada
Sažeci sa skupova, sažetak, znanstveni
Izvornik
The Seventh ISABS Conference in Forensic, Anthropologic and Medical Genetics and Mayo Clinic Lectures in Translational Medicine ; Final Program and Abstracts
/ Schanfield, Moses ; Primorac, Dragan ; Vuk-Pavlović, Stanimir - , 2011, 246-246
Skup
Peti hrvatski kongres iz humane genetke
Mjesto i datum
Bol, Hrvatska, 20.06.2011. - 21.06.2011
Vrsta sudjelovanja
Predavanje
Vrsta recenzije
Međunarodna recenzija
Ključne riječi
shizofrenija; shizoafektivni poremećaj; mutacije u genu za hemokromatozu; C1/C2 polimorfizam gena za transferin; dob prve hospitalizacije
(Schizophrenia; Schizoaffective disorder; Hemochromatosis gene mutations; Transferrin gene variant; Age at first hospital admission)
Sažetak
OBJECTIVE: To investigate the possible influence of hemochromatosis gene mutations (HFE-C282Y and H63D) and transferrin gene C2 variant (TF-C2) on susceptibility to schizophrenia and schizoaffective disorder and/or age at first hospital admission. METHODS: Genotyping was performed in 176 Croatian patients and 171 non-psychiatric Croatian controls using PCR-RFLP analyses. RESULTS: Allele and genotype distributions were not significantly different between two groups. After the age at first admission was analyzed as a continuous variable using the non-parametric Mann-Whitney U-test and Kruskal-Wallis test with negative results, the variable was dichotomized using 40 years as the cutoff. H63D-TFC2 bi-carriers were over-represented among patients in the late disease-onset group [≥ 40 years ; 7.5% vs. 25%, odds ratio (OR) = 0.243, 95% confidence interval (CI) = 0.068-0.871 ; P=0.030]. Multiple regression analysis showed no effect of combined H63D-TFC2 genotype to distribution of age at disease-onset in our sample. CONCLUSION: Investigated HFE mutations and TF-C2 variant are not high-risk genetic variants for schizophrenia/schizoaffective disorder in our population. Also, our data do not support their impact on age at onset of the first psychotic symptoms.
Izvorni jezik
Hrvatski
Znanstvena područja
Temeljne medicinske znanosti
POVEZANOST RADA
Projekti:
062-0982522-0369 - Genetika metabolizma fosfolipida u shizofreniji (Buretić-Tomljanović, Alena, MZOS ) ( CroRIS)
Ustanove:
Medicinski fakultet, Rijeka,
Klinički bolnički centar Rijeka
Profili:
Vesna Šendula-Jengić
(autor)
Gordana Rubeša
(autor)
Suzana Jonovska
(autor)
Smiljana Ristić
(autor)
Alena Buretić-Tomljanović
(autor)
Miljenko Kapović
(autor)
Jadranka Vraneković
(autor)